Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATALIZUMAB for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 492 adverse event reports in the FDA FAERS database where NATALIZUMAB was used for Maternal exposure timing unspecified.

Most Reported Side Effects for NATALIZUMAB

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 6,478 10.1% 96 3,253
Fatigue 4,456 6.9% 22 690
Multiple sclerosis 4,078 6.3% 197 1,117
Memory impairment 3,024 4.7% 5 426
Malaise 2,523 3.9% 30 461
Fall 2,481 3.9% 51 1,330
Headache 2,476 3.9% 14 530
Gait disturbance 2,427 3.8% 13 696
Prescribed underdose 2,162 3.4% 56 545
Maternal exposure during pregnancy 1,948 3.0% 6 357
Asthenia 1,945 3.0% 36 658
Pain 1,911 3.0% 15 540
Urinary tract infection 1,894 2.9% 85 1,072
Drug ineffective 1,757 2.7% 28 350
Progressive multifocal leukoencephalopathy 1,668 2.6% 279 1,201

Other Indications for NATALIZUMAB

Multiple sclerosis (56,733) Product used for unknown indication (3,472) Relapsing-remitting multiple sclerosis (2,749) Crohn's disease (281) Relapsing multiple sclerosis (140) Secondary progressive multiple sclerosis (115) Primary progressive multiple sclerosis (27) Paternal exposure timing unspecified (26) Exposure via partner (24) Disease risk factor (23)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169) DARUNAVIR ETHANOLATE (154)

Related Pages

NATALIZUMAB Full Profile All Maternal exposure timing unspecified Drugs NATALIZUMAB Demographics NATALIZUMAB Timeline